‌

US Patent 8063187 Methods and compositions for inhibiting CD32B expressing cells

Patent 8063187 was granted and assigned to Xencor on November, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Igor Vostiar0

Gregory Alan Lazar0

Gregory L. Moore0

John R. Desjarlais0

Seung Yup Chu0

Sher Bahadur Karki0

Date of Patent

November 22, 2011

0

Patent Application Number

121561830

Date Filed

May 30, 2008

0

Patent Citations Received

US Patent 11945880 Heterodimeric antibodies that bind CD3 and tumor antigens

0

US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38

0

US Patent 12084513 Anti-C1S antibodies and methods of use

0

US Patent 11780912 Composition for prophylaxis or treatment of IL-8 related diseases

US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens

0

0

US Patent 11674958 Capture, purification, and release of biological substances using a surface coating

0

US Patent 11840579 Bispecific antibodies that bind to CD38 and CD3

0

...

Patent Primary Examiner

0

Patent abstract

The present invention relates to immunoglobulins that bind FcγRIIb+ cells and coengage the antigen on the cell's surface and an FcγRIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8063187 Methods and compositions for inhibiting CD32B expressing cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.